nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—Hyperthyroidism—Levothyroxine—hypothyroidism	0.0293	0.0479	CcSEcCtD
Epoprostenol—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.0293	0.0479	CcSEcCtD
Epoprostenol—Hyperthyroidism—Liotrix—hypothyroidism	0.0216	0.0352	CcSEcCtD
Epoprostenol—PTGIS—heart—hypothyroidism	0.0209	0.0755	CbGeAlD
Epoprostenol—PTGIS—cardiovascular system—hypothyroidism	0.0197	0.0712	CbGeAlD
Epoprostenol—P2RY12—cardiovascular system—hypothyroidism	0.0177	0.0642	CbGeAlD
Epoprostenol—CYP2C9—urine—hypothyroidism	0.0167	0.0605	CbGeAlD
Epoprostenol—PTGIS—adrenal gland—hypothyroidism	0.0156	0.0564	CbGeAlD
Epoprostenol—PTGIS—thyroid gland—hypothyroidism	0.015	0.0544	CbGeAlD
Epoprostenol—PTGIS—female gonad—hypothyroidism	0.0145	0.0525	CbGeAlD
Epoprostenol—P2RY12—blood—hypothyroidism	0.014	0.0507	CbGeAlD
Epoprostenol—PTGER1—female gonad—hypothyroidism	0.0135	0.0489	CbGeAlD
Epoprostenol—Acute coronary syndrome—Liothyronine—hypothyroidism	0.013	0.0212	CcSEcCtD
Epoprostenol—Myocardial infarction—Liothyronine—hypothyroidism	0.0129	0.0211	CcSEcCtD
Epoprostenol—PTGIS—testis—hypothyroidism	0.0129	0.0466	CbGeAlD
Epoprostenol—PTGIS—liver—hypothyroidism	0.0122	0.0441	CbGeAlD
Epoprostenol—Cyanosis—Liotrix—hypothyroidism	0.012	0.0197	CcSEcCtD
Epoprostenol—PTGIR—heart—hypothyroidism	0.012	0.0434	CbGeAlD
Epoprostenol—PTGIR—cardiovascular system—hypothyroidism	0.0113	0.0409	CbGeAlD
Epoprostenol—PTGIR—gonad—hypothyroidism	0.0103	0.0371	CbGeAlD
Epoprostenol—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.0101	0.0165	CcSEcCtD
Epoprostenol—Hyperkinesia—Levothyroxine—hypothyroidism	0.0101	0.0165	CcSEcCtD
Epoprostenol—Cellulitis—Liotrix—hypothyroidism	0.00937	0.0153	CcSEcCtD
Epoprostenol—PTGIR—adrenal gland—hypothyroidism	0.00894	0.0324	CbGeAlD
Epoprostenol—PTGIR—blood—hypothyroidism	0.00894	0.0324	CbGeAlD
Epoprostenol—PTGIR—thyroid gland—hypothyroidism	0.00863	0.0312	CbGeAlD
Epoprostenol—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00862	0.0141	CcSEcCtD
Epoprostenol—Cardiac failure—Levothyroxine—hypothyroidism	0.00862	0.0141	CcSEcCtD
Epoprostenol—PTGIR—female gonad—hypothyroidism	0.00834	0.0302	CbGeAlD
Epoprostenol—Tachycardia—Liothyronine—hypothyroidism	0.00821	0.0134	CcSEcCtD
Epoprostenol—Hypotension—Liothyronine—hypothyroidism	0.00786	0.0128	CcSEcCtD
Epoprostenol—PTGIS—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00757	0.0679	CbGpPWpGaD
Epoprostenol—Hyperkinesia—Liotrix—hypothyroidism	0.00743	0.0121	CcSEcCtD
Epoprostenol—Sepsis—Liotrix—hypothyroidism	0.00739	0.0121	CcSEcCtD
Epoprostenol—PTGIR—testis—hypothyroidism	0.00739	0.0268	CbGeAlD
Epoprostenol—PTGIR—liver—hypothyroidism	0.00699	0.0253	CbGeAlD
Epoprostenol—PTGIR—cerebellum—hypothyroidism	0.00683	0.0247	CbGeAlD
Epoprostenol—Body temperature increased—Liothyronine—hypothyroidism	0.00665	0.0109	CcSEcCtD
Epoprostenol—Weight decreased—Levothyroxine—hypothyroidism	0.00657	0.0107	CcSEcCtD
Epoprostenol—Weight decreased—Dextrothyroxine—hypothyroidism	0.00657	0.0107	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00639	0.0104	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00639	0.0104	CcSEcCtD
Epoprostenol—Myocardial infarction—Levothyroxine—hypothyroidism	0.00635	0.0104	CcSEcCtD
Epoprostenol—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00635	0.0104	CcSEcCtD
Epoprostenol—Cardiac failure—Liotrix—hypothyroidism	0.00634	0.0104	CcSEcCtD
Epoprostenol—Sweating—Dextrothyroxine—hypothyroidism	0.00621	0.0101	CcSEcCtD
Epoprostenol—Sweating—Levothyroxine—hypothyroidism	0.00621	0.0101	CcSEcCtD
Epoprostenol—PTGIS—Endogenous sterols—POMC—hypothyroidism	0.00555	0.0498	CbGpPWpGaD
Epoprostenol—PTGER1—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00554	0.0497	CbGpPWpGaD
Epoprostenol—PTGIR—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00554	0.0497	CbGpPWpGaD
Epoprostenol—Flushing—Dextrothyroxine—hypothyroidism	0.0054	0.00882	CcSEcCtD
Epoprostenol—Flushing—Levothyroxine—hypothyroidism	0.0054	0.00882	CcSEcCtD
Epoprostenol—Abdominal distension—Liotrix—hypothyroidism	0.00538	0.00879	CcSEcCtD
Epoprostenol—Tension—Dextrothyroxine—hypothyroidism	0.00497	0.00812	CcSEcCtD
Epoprostenol—Tension—Levothyroxine—hypothyroidism	0.00497	0.00812	CcSEcCtD
Epoprostenol—Nervousness—Levothyroxine—hypothyroidism	0.00492	0.00803	CcSEcCtD
Epoprostenol—Nervousness—Dextrothyroxine—hypothyroidism	0.00492	0.00803	CcSEcCtD
Epoprostenol—Weight decreased—Liotrix—hypothyroidism	0.00484	0.0079	CcSEcCtD
Epoprostenol—Tremor—Dextrothyroxine—hypothyroidism	0.00474	0.00775	CcSEcCtD
Epoprostenol—Tremor—Levothyroxine—hypothyroidism	0.00474	0.00775	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Liotrix—hypothyroidism	0.0047	0.00767	CcSEcCtD
Epoprostenol—Myocardial infarction—Liotrix—hypothyroidism	0.00467	0.00763	CcSEcCtD
Epoprostenol—Agitation—Dextrothyroxine—hypothyroidism	0.00465	0.0076	CcSEcCtD
Epoprostenol—Agitation—Levothyroxine—hypothyroidism	0.00465	0.0076	CcSEcCtD
Epoprostenol—Sweating—Liotrix—hypothyroidism	0.00457	0.00746	CcSEcCtD
Epoprostenol—Palpitations—Dextrothyroxine—hypothyroidism	0.00447	0.00731	CcSEcCtD
Epoprostenol—Palpitations—Levothyroxine—hypothyroidism	0.00447	0.00731	CcSEcCtD
Epoprostenol—Arthralgia—Levothyroxine—hypothyroidism	0.00431	0.00704	CcSEcCtD
Epoprostenol—Arthralgia—Dextrothyroxine—hypothyroidism	0.00431	0.00704	CcSEcCtD
Epoprostenol—Anxiety—Levothyroxine—hypothyroidism	0.0043	0.00702	CcSEcCtD
Epoprostenol—Anxiety—Dextrothyroxine—hypothyroidism	0.0043	0.00702	CcSEcCtD
Epoprostenol—CYP2C9—heart—hypothyroidism	0.00428	0.0155	CbGeAlD
Epoprostenol—Hypoaesthesia—Liotrix—hypothyroidism	0.00426	0.00695	CcSEcCtD
Epoprostenol—Confusional state—Dextrothyroxine—hypothyroidism	0.00417	0.00681	CcSEcCtD
Epoprostenol—Confusional state—Levothyroxine—hypothyroidism	0.00417	0.00681	CcSEcCtD
Epoprostenol—Shock—Levothyroxine—hypothyroidism	0.00407	0.00664	CcSEcCtD
Epoprostenol—Shock—Dextrothyroxine—hypothyroidism	0.00407	0.00664	CcSEcCtD
Epoprostenol—CYP2C9—cardiovascular system—hypothyroidism	0.00404	0.0146	CbGeAlD
Epoprostenol—Tachycardia—Levothyroxine—hypothyroidism	0.00403	0.00659	CcSEcCtD
Epoprostenol—Tachycardia—Dextrothyroxine—hypothyroidism	0.00403	0.00659	CcSEcCtD
Epoprostenol—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.004	0.00652	CcSEcCtD
Epoprostenol—Hyperhidrosis—Levothyroxine—hypothyroidism	0.004	0.00652	CcSEcCtD
Epoprostenol—Flushing—Liotrix—hypothyroidism	0.00397	0.00649	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00377	0.00615	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00377	0.00615	CcSEcCtD
Epoprostenol—Insomnia—Dextrothyroxine—hypothyroidism	0.00374	0.0061	CcSEcCtD
Epoprostenol—Insomnia—Levothyroxine—hypothyroidism	0.00374	0.0061	CcSEcCtD
Epoprostenol—Dyspnoea—Levothyroxine—hypothyroidism	0.00368	0.00602	CcSEcCtD
Epoprostenol—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00368	0.00602	CcSEcCtD
Epoprostenol—Flatulence—Liotrix—hypothyroidism	0.00367	0.00599	CcSEcCtD
Epoprostenol—Tension—Liotrix—hypothyroidism	0.00366	0.00597	CcSEcCtD
Epoprostenol—Nervousness—Liotrix—hypothyroidism	0.00362	0.00591	CcSEcCtD
Epoprostenol—Fatigue—Dextrothyroxine—hypothyroidism	0.00356	0.00582	CcSEcCtD
Epoprostenol—Fatigue—Levothyroxine—hypothyroidism	0.00356	0.00582	CcSEcCtD
Epoprostenol—Tremor—Liotrix—hypothyroidism	0.00349	0.0057	CcSEcCtD
Epoprostenol—Agitation—Liotrix—hypothyroidism	0.00342	0.00559	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00338	0.00552	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00338	0.00552	CcSEcCtD
Epoprostenol—Syncope—Liotrix—hypothyroidism	0.00334	0.00546	CcSEcCtD
Epoprostenol—Palpitations—Liotrix—hypothyroidism	0.00329	0.00538	CcSEcCtD
Epoprostenol—Urticaria—Dextrothyroxine—hypothyroidism	0.00328	0.00536	CcSEcCtD
Epoprostenol—Urticaria—Levothyroxine—hypothyroidism	0.00328	0.00536	CcSEcCtD
Epoprostenol—Loss of consciousness—Liotrix—hypothyroidism	0.00327	0.00535	CcSEcCtD
Epoprostenol—Body temperature increased—Levothyroxine—hypothyroidism	0.00327	0.00534	CcSEcCtD
Epoprostenol—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00327	0.00534	CcSEcCtD
Epoprostenol—Abdominal pain—Levothyroxine—hypothyroidism	0.00327	0.00534	CcSEcCtD
Epoprostenol—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00327	0.00534	CcSEcCtD
Epoprostenol—CYP2C9—blood—hypothyroidism	0.00319	0.0116	CbGeAlD
Epoprostenol—Chest pain—Liotrix—hypothyroidism	0.00317	0.00518	CcSEcCtD
Epoprostenol—Arthralgia—Liotrix—hypothyroidism	0.00317	0.00518	CcSEcCtD
Epoprostenol—Anxiety—Liotrix—hypothyroidism	0.00316	0.00516	CcSEcCtD
Epoprostenol—Confusional state—Liotrix—hypothyroidism	0.00307	0.00501	CcSEcCtD
Epoprostenol—Oedema—Liotrix—hypothyroidism	0.00304	0.00496	CcSEcCtD
Epoprostenol—Anaphylactic shock—Liotrix—hypothyroidism	0.00304	0.00496	CcSEcCtD
Epoprostenol—Infection—Liotrix—hypothyroidism	0.00302	0.00493	CcSEcCtD
Epoprostenol—Shock—Liotrix—hypothyroidism	0.00299	0.00488	CcSEcCtD
Epoprostenol—Tachycardia—Liotrix—hypothyroidism	0.00297	0.00485	CcSEcCtD
Epoprostenol—Asthenia—Levothyroxine—hypothyroidism	0.00297	0.00484	CcSEcCtD
Epoprostenol—Asthenia—Dextrothyroxine—hypothyroidism	0.00297	0.00484	CcSEcCtD
Epoprostenol—Hyperhidrosis—Liotrix—hypothyroidism	0.00294	0.0048	CcSEcCtD
Epoprostenol—Pruritus—Levothyroxine—hypothyroidism	0.00292	0.00478	CcSEcCtD
Epoprostenol—Pruritus—Dextrothyroxine—hypothyroidism	0.00292	0.00478	CcSEcCtD
Epoprostenol—Anorexia—Liotrix—hypothyroidism	0.0029	0.00473	CcSEcCtD
Epoprostenol—Hypotension—Liotrix—hypothyroidism	0.00284	0.00464	CcSEcCtD
Epoprostenol—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00283	0.00462	CcSEcCtD
Epoprostenol—Diarrhoea—Levothyroxine—hypothyroidism	0.00283	0.00462	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00277	0.00452	CcSEcCtD
Epoprostenol—Insomnia—Liotrix—hypothyroidism	0.00275	0.00449	CcSEcCtD
Epoprostenol—Paraesthesia—Liotrix—hypothyroidism	0.00273	0.00446	CcSEcCtD
Epoprostenol—Dyspnoea—Liotrix—hypothyroidism	0.00271	0.00443	CcSEcCtD
Epoprostenol—PTGIR—G alpha (s) signalling events—TSHB—hypothyroidism	0.00269	0.0242	CbGpPWpGaD
Epoprostenol—PTGIR—G alpha (s) signalling events—TSHR—hypothyroidism	0.00269	0.0242	CbGpPWpGaD
Epoprostenol—Decreased appetite—Liotrix—hypothyroidism	0.00264	0.00432	CcSEcCtD
Epoprostenol—Vomiting—Levothyroxine—hypothyroidism	0.00263	0.00429	CcSEcCtD
Epoprostenol—Vomiting—Dextrothyroxine—hypothyroidism	0.00263	0.00429	CcSEcCtD
Epoprostenol—Fatigue—Liotrix—hypothyroidism	0.00262	0.00428	CcSEcCtD
Epoprostenol—Rash—Dextrothyroxine—hypothyroidism	0.00261	0.00426	CcSEcCtD
Epoprostenol—Rash—Levothyroxine—hypothyroidism	0.00261	0.00426	CcSEcCtD
Epoprostenol—Dermatitis—Levothyroxine—hypothyroidism	0.0026	0.00425	CcSEcCtD
Epoprostenol—Dermatitis—Dextrothyroxine—hypothyroidism	0.0026	0.00425	CcSEcCtD
Epoprostenol—Constipation—Liotrix—hypothyroidism	0.0026	0.00425	CcSEcCtD
Epoprostenol—Headache—Dextrothyroxine—hypothyroidism	0.00259	0.00423	CcSEcCtD
Epoprostenol—Headache—Levothyroxine—hypothyroidism	0.00259	0.00423	CcSEcCtD
Epoprostenol—PTGIS—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00258	0.0231	CbGpPWpGaD
Epoprostenol—CYP2C9—liver—hypothyroidism	0.0025	0.00904	CbGeAlD
Epoprostenol—Gastrointestinal pain—Liotrix—hypothyroidism	0.00249	0.00406	CcSEcCtD
Epoprostenol—Nausea—Levothyroxine—hypothyroidism	0.00245	0.00401	CcSEcCtD
Epoprostenol—Nausea—Dextrothyroxine—hypothyroidism	0.00245	0.00401	CcSEcCtD
Epoprostenol—Urticaria—Liotrix—hypothyroidism	0.00241	0.00394	CcSEcCtD
Epoprostenol—Body temperature increased—Liotrix—hypothyroidism	0.0024	0.00392	CcSEcCtD
Epoprostenol—Abdominal pain—Liotrix—hypothyroidism	0.0024	0.00392	CcSEcCtD
Epoprostenol—Hypersensitivity—Liotrix—hypothyroidism	0.00224	0.00366	CcSEcCtD
Epoprostenol—Asthenia—Liotrix—hypothyroidism	0.00218	0.00356	CcSEcCtD
Epoprostenol—PTGER1—G alpha (q) signalling events—TRH—hypothyroidism	0.00218	0.0195	CbGpPWpGaD
Epoprostenol—Pruritus—Liotrix—hypothyroidism	0.00215	0.00351	CcSEcCtD
Epoprostenol—PTGIS—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00209	0.0187	CbGpPWpGaD
Epoprostenol—Diarrhoea—Liotrix—hypothyroidism	0.00208	0.0034	CcSEcCtD
Epoprostenol—Dizziness—Liotrix—hypothyroidism	0.00201	0.00328	CcSEcCtD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00195	0.0175	CbGpPWpGaD
Epoprostenol—Vomiting—Liotrix—hypothyroidism	0.00193	0.00316	CcSEcCtD
Epoprostenol—Rash—Liotrix—hypothyroidism	0.00192	0.00313	CcSEcCtD
Epoprostenol—Dermatitis—Liotrix—hypothyroidism	0.00191	0.00313	CcSEcCtD
Epoprostenol—Headache—Liotrix—hypothyroidism	0.0019	0.00311	CcSEcCtD
Epoprostenol—Nausea—Liotrix—hypothyroidism	0.00181	0.00295	CcSEcCtD
Epoprostenol—PTGIR—G alpha (s) signalling events—AVP—hypothyroidism	0.00159	0.0142	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00157	0.014	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00144	0.0129	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00144	0.0129	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.0014	0.0125	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.0014	0.0125	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—IGF1—hypothyroidism	0.00134	0.012	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—IYD—hypothyroidism	0.00131	0.0117	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00128	0.0115	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00128	0.0115	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00128	0.0115	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00128	0.0115	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—TRH—hypothyroidism	0.00119	0.0107	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—AVP—hypothyroidism	0.00114	0.0102	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.00113	0.0101	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ATP5O—hypothyroidism	0.00111	0.00998	CbGpPWpGaD
Epoprostenol—PTGIS—Biological oxidations—POMC—hypothyroidism	0.00111	0.00995	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—TRH—hypothyroidism	0.0011	0.00984	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—TRH—hypothyroidism	0.0011	0.00984	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—TSHB—hypothyroidism	0.00106	0.00953	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—TSHR—hypothyroidism	0.00106	0.00953	CbGpPWpGaD
Epoprostenol—PTGIR—G alpha (s) signalling events—POMC—hypothyroidism	0.00106	0.00946	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—TPO—hypothyroidism	0.00105	0.00938	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00102	0.00917	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—TSHR—hypothyroidism	0.000978	0.00877	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—TSHR—hypothyroidism	0.000978	0.00877	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—TSHB—hypothyroidism	0.000978	0.00877	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—TSHB—hypothyroidism	0.000978	0.00877	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00097	0.00869	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—SH2B3—hypothyroidism	0.000847	0.0076	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000823	0.00738	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—SH2B3—hypothyroidism	0.00078	0.00699	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000757	0.00679	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000757	0.00679	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000695	0.00623	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—POMC—hypothyroidism	0.000688	0.00616	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—TRH—hypothyroidism	0.000674	0.00604	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—AVP—hypothyroidism	0.000626	0.00562	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—TRH—hypothyroidism	0.00062	0.00556	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—TRH—hypothyroidism	0.00062	0.00556	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—TRH—hypothyroidism	0.000612	0.00549	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—TSHB—hypothyroidism	0.000601	0.00539	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—TSHR—hypothyroidism	0.000601	0.00539	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—VAV3—hypothyroidism	0.000581	0.00521	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—AVP—hypothyroidism	0.000576	0.00517	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—AVP—hypothyroidism	0.000576	0.00517	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—TRH—hypothyroidism	0.000563	0.00505	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—TRH—hypothyroidism	0.000563	0.00505	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—TSHB—hypothyroidism	0.000553	0.00496	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—TSHR—hypothyroidism	0.000553	0.00496	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—TSHB—hypothyroidism	0.000553	0.00496	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—TSHR—hypothyroidism	0.000553	0.00496	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000547	0.0049	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—TSHB—hypothyroidism	0.000545	0.00489	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—TSHR—hypothyroidism	0.000545	0.00489	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—VAV3—hypothyroidism	0.000535	0.0048	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000503	0.00451	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000503	0.00451	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—TSHB—hypothyroidism	0.000502	0.0045	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—TSHB—hypothyroidism	0.000502	0.0045	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—TSHR—hypothyroidism	0.000502	0.0045	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—TSHR—hypothyroidism	0.000502	0.0045	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—TSHB—hypothyroidism	0.000485	0.00434	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PIK3C2A—hypothyroidism	0.000432	0.00387	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000426	0.00382	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CLTC—hypothyroidism	0.000418	0.00375	CbGpPWpGaD
Epoprostenol—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000416	0.00373	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—POMC—hypothyroidism	0.000416	0.00373	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CLTC—hypothyroidism	0.000385	0.00345	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CLTC—hypothyroidism	0.000385	0.00345	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—POMC—hypothyroidism	0.000383	0.00344	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—POMC—hypothyroidism	0.000383	0.00344	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PRL—hypothyroidism	0.000383	0.00343	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—VAV3—hypothyroidism	0.000367	0.00329	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—SLC5A5—hypothyroidism	0.000363	0.00325	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TRH—hypothyroidism	0.000362	0.00324	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IGF1—hypothyroidism	0.000358	0.00321	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—AVP—hypothyroidism	0.000354	0.00317	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—VAV3—hypothyroidism	0.000338	0.00303	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—VAV3—hypothyroidism	0.000338	0.00303	CbGpPWpGaD
Epoprostenol—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000338	0.00303	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—VAV3—hypothyroidism	0.000334	0.00299	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TRH—hypothyroidism	0.000333	0.00298	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TRH—hypothyroidism	0.000333	0.00298	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IGF1—hypothyroidism	0.00033	0.00295	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—AVP—hypothyroidism	0.000326	0.00292	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—AVP—hypothyroidism	0.000326	0.00292	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TSHB—hypothyroidism	0.000322	0.00289	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TSHR—hypothyroidism	0.000322	0.00289	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—AVP—hypothyroidism	0.000321	0.00288	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—VAV3—hypothyroidism	0.000307	0.00275	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—VAV3—hypothyroidism	0.000307	0.00275	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TSHR—hypothyroidism	0.000297	0.00266	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TSHB—hypothyroidism	0.000297	0.00266	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TSHB—hypothyroidism	0.000297	0.00266	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TSHR—hypothyroidism	0.000297	0.00266	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AVP—hypothyroidism	0.000296	0.00265	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AVP—hypothyroidism	0.000296	0.00265	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SH2B3—hypothyroidism	0.000287	0.00258	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SH2B3—hypothyroidism	0.000264	0.00237	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SH2B3—hypothyroidism	0.000264	0.00237	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—POMC—hypothyroidism	0.000235	0.00211	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—POMC—hypothyroidism	0.000216	0.00194	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—POMC—hypothyroidism	0.000216	0.00194	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—POMC—hypothyroidism	0.000214	0.00192	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PRL—hypothyroidism	0.000213	0.00191	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—IYD—hypothyroidism	0.000212	0.0019	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VAV3—hypothyroidism	0.000197	0.00177	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—POMC—hypothyroidism	0.000197	0.00176	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—POMC—hypothyroidism	0.000197	0.00176	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PRL—hypothyroidism	0.000196	0.00176	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PRL—hypothyroidism	0.000196	0.00176	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AVP—hypothyroidism	0.00019	0.0017	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—POMC—hypothyroidism	0.00019	0.0017	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VAV3—hypothyroidism	0.000181	0.00163	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VAV3—hypothyroidism	0.000181	0.00163	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ATP5O—hypothyroidism	0.00018	0.00161	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—POMC—hypothyroidism	0.000179	0.00161	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AVP—hypothyroidism	0.000175	0.00157	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AVP—hypothyroidism	0.000175	0.00157	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TPO—hypothyroidism	0.000169	0.00152	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000157	0.0014	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—POMC—hypothyroidism	0.000126	0.00113	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IGF1—hypothyroidism	0.000121	0.00109	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—POMC—hypothyroidism	0.000116	0.00104	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—POMC—hypothyroidism	0.000116	0.00104	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IGF1—hypothyroidism	0.000112	0.001	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IGF1—hypothyroidism	0.000112	0.001	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TSHB—hypothyroidism	7.83e-05	0.000702	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	6.98e-05	0.000626	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.89e-05	0.000617	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC5A5—hypothyroidism	5.86e-05	0.000526	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—POMC—hypothyroidism	3.07e-05	0.000275	CbGpPWpGaD
